SCHEMBL14433862

SCHEMBL14433862

CCCC(=N)N1CCC(C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
PHGDH O43175 1/20 0.45
MGLL Q99685 1/20 0.45
ALDH1A1 P00352 7/20 0.42
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 6/20 0.36
POLB P06746 3/20 0.35
MAPT P10636 3/20 0.35
LIPE Q05469 1/20 0.35
ACHE P22303 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
GAA P10253 1/20 0.34
RAB9A P51151 2/20 0.33
HTT P42858 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14433874 0.76 F2 (0.48) PHGDHMGLLALDH1A1MEN1KMT2A
SCHEMBL10274470 0.75 NPC1 (0.74) NPC1ALDH1A1MEN1KMT2AHPGD
SCHEMBL25824843 0.75 NPC1 (0.47) NPC1PHGDHMGLLALDH1A1MEN1
SCHEMBL14434063 0.74 MGLL (0.41) NPC1PHGDHMGLLALDH1A1CYP1A2
SCHEMBL21131463 0.73 PHGDH (0.44) NPC1PHGDHMGLLALDH1A1MEN1
SCHEMBL349335 0.73 F2 (0.50) NPC1PHGDHMGLLALDH1A1MEN1
SCHEMBL9061263 0.73 F2 (0.50) NPC1PHGDHMGLLALDH1A1MEN1
SCHEMBL14434111 0.72 HSD11B1 (0.39) ALDH1A1HPGDMAPTCYP1A2CYP2C9
SCHEMBL14433876 0.72 HTT (0.42) PHGDHMGLLALDH1A1POLBRECQL
SCHEMBL24052080 0.72 PHGDH (0.50) NPC1PHGDHMGLLALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007087204-A2 HETEROCYCLES AS NICOTINIC ACID RECEPTOR AGONISTS FOR THE TREATMENT OF DYYSLIPIDEMIA SCHERING CORPOORATION (US) 2007-08-02 WO disclosed